文献速递乳腺癌放疗放疗物理与技术

乳腺密度直方图分析:脂肪在全乳放疗后结局预测中的作用

Breast Density Histogram Analysis: The Role of Fat in Outcome Prediction After Whole Breast Radiation Therapy.
PubMed 文献 · Pract Radiat Oncol · 2025-12-13

本研究基于1127例接受40 Gy/15次全乳放疗的早期乳腺癌患者,利用计划CT的HU直方图量化脂肪与纤维腺体组织,发现脂肪体积百分比和HU百分位与结局中度相关,临床特征预测最强,联合模型可改善远处进展预测。

要点

  • 脂肪体积百分比升高和较低HU值与更好的结局相关。
  • 临床模型预测性能高于密度模型,联合模型改善远处进展预测。
  • 密度学指标与分子亚型无显著关联。

核心结论

  • 临床特征是 strongest 预测因子,脂肪相关指标提供额外生物学信息并改善局部和远处复发预测。

研究设计与样本

  • 单中心队列纳入1127例早期乳腺癌患者,接受40 Gy/15次全乳放疗(2009-2017)。
  • 从计划CT提取HU直方图(范围-200 HU至+50 HU),量化脂肪与纤维腺体组织。
  • 采用多变量Cox回归构建密度学、临床和联合预测模型,1000次bootstrap内部验证。

主要发现

  • 中位随访6年(四分位距4-8),局部复发/远处复发/死亡率分别为2.3%/4.1%/7.0%。
  • 密度学模型(脂肪体积百分比和HU百分位组合)与结局中度相关,C指数0.60-0.61。
  • 较低HU值和较高脂肪体积百分比与更好结局相关。
  • 临床模型C指数0.72-0.76,关键因素包括肿瘤分期、淋巴结状态、年龄和三阴性乳腺癌亚型。
  • 联合模型C指数0.71-0.79,改善临床模型对远处无进展生存的预测。

关键数值与推荐

  • HU直方图提取范围-200 HU至+50 HU,排除夹子和伪影。
  • 密度学模型C指数0.60-0.61,临床模型C指数0.72-0.76,联合模型C指数0.71-0.79。

临床怎么用

  • 临床特征仍是主要预后工具,脂肪相关密度指标可辅助改善局部和远处复发预测。
  • 基于计划CT的密度分析可能促进治疗个体化和患者分层。

局限性

  • 单中心回顾性队列,需外部验证。
  • 密度学模型预测性能中等,临床模型仍占主导。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Although the link between breast tissue density and cancer risk is well established, its influence on posttreatment outcomes remains unclear. Clarifying the role of breast density in these outcomes could enhance treatment personalization and patient stratification, potentially enabling clinicians to adapt radiation therapy plans to individual breast tissue composition. This study evaluated the role of pre-radiation therapy breast densitometric state in relation to local/distant progression, overall survival, and molecular subtypes. METHODS AND MATERIALS: A mono-institutional cohort of 1127 early-stage breast cancer patients treated with 40 Gy/15 fractions (2009-2017) was analyzed. Clinical target volume segmentations from planning computed tomography were used to extract hounsfield units (HU) histograms (range, -200 HU, +50 HU), excluding clips and artifacts. Fatty and fibroglandular tissues were quantified based on selected HU ranges. Extracted parameters included volume, mean/median HU, standard deviation, percentiles, and histogram shape indices. Densitometric, clinical, and combined predictive models were developed using multivariate Cox regression, minimizing redundancy. Internal validation involved 1000 bootstrap iterations. A prognostic index was calculated for each model, and Kaplan-Meier analysis stratified patients into risk groups. Densitometric prognostic indices were also tested for potential association with molecular subtypes (luminal A/B, Her2+, triple-negative breast cancer). RESULTS: Median follow-up was 6 years (interquartile range, 4-8): local relapse/distant relapse/death rates were 2.3%/4.1%/7.0%, respectively. The combination of % fat volume (VFAT%) and HU percentiles was moderately associated with outcomes (densitometry models, C-index, 0.60-0.61): lower HU values and higher VFAT% were associated to better outcome. Clinical models showed higher predictive performance (C-index, 0.72-0.76), with key factors including tumor stage, nodal status, age, and triple-negative breast cancer subtype. Combined models (C-index, 0.71-0.79) improved the performances of the clinical model for distant progression-free survival. No significant association was found between densitometric models and molecular subtypes. CONCLUSIONS: Clinical features are the strongest predictors, though fat-related metrics offered additional biological insights, improving the ability of local and distant relapse prediction.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Mori M, Belardo A, Vincenzi MM, et al. Breast Density Histogram Analysis: The Role of Fat in Outcome Prediction After Whole Breast Radiation Therapy. Pract Radiat Oncol. 2025. PMID: 41397616. doi:10.1016/j.prro.2025.12.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。